Multiple endocrine neoplasia type 2 primary prevention: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Multiple endocrine neoplasia type 2}} | {{Multiple endocrine neoplasia type 2}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{USAMA}} | ||
==Overview== | ==Overview== | ||
There are no primary preventive measures for multiple endocrine neoplasia type 2. | There are no primary preventive measures for multiple endocrine neoplasia type 2. | ||
==Primary Prevention== | ==Primary Prevention== | ||
There are no primary preventive measures for multiple endocrine neoplasia type 2. | There are no primary preventive measures for multiple endocrine neoplasia type 2. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 16:32, 25 October 2017
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 primary prevention On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 primary prevention |
FDA on Multiple endocrine neoplasia type 2 primary prevention |
CDC on Multiple endocrine neoplasia type 2 primary prevention |
Multiple endocrine neoplasia type 2 primary prevention in the news |
Blogs on Multiple endocrine neoplasia type 2 primary prevention |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Overview
There are no primary preventive measures for multiple endocrine neoplasia type 2.
Primary Prevention
There are no primary preventive measures for multiple endocrine neoplasia type 2.